SecBot SecBot
6-K ·Filed Jul 21, 2026

SNN

SMITH & NEPHEW PLC
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001654954-26-006756
Notable filing: 6-K
Actionable Insight • Neutral

Routine ESPP purchases by PDMRs, no trading signal. Monitor next quarterly earnings for operational trends; the 20-F annual report (filed March 2026) provides the most recent financial context.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$30.21
T+0 close · Jul 21, 2026 · via day close
Latest settled
−7.78%
T+60 · $27.86
Vs SPY
−11.75%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 21 $30.21entry
  2. T+1 · 4mo ago −0.89%α −0.78% · $29.94
  3. T+5 · 4mo ago +3.01%α +4.24% · $31.12
  4. T+20 · 3mo ago −0.07%α −2.63% · $30.19
  5. T+60 · 5w ago −7.78%α −11.75% · $27.86
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Smith & Nephew filed a Form 6-K disclosing routine purchases of American Depositary Shares (ADS) by the CEO and two other PDMRs through the company's Employee Stock Purchase Plan at $24.48 per share. The total value of the purchases is approximately $27,500, which is immaterial relative to the company's $12.9B market cap. This is a standard administrative disclosure with no trading signal.

Key Facts

  • CEO Deepak Nath purchased 434 ADS at $24.48 on 2026-07-10
  • President of Global Operations Paul Connolly purchased 434 ADS at $24.48
  • President of Sports Medicine Scott Schaffner purchased 257 ADS at $24.48
  • Total purchase value approximately $27,500
  • Purchases were made through the company's Employee Stock Purchase Plan

Financial Impact

Total insider purchases of approximately $27,500, immaterial for a $12.9B market cap company

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
OTC
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
50% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-006756
Document: 0001654954-26-006756-index-headers.html0001654954-26-006756
Document: 0001654954-26-006756-index.html0001654954-26-006756
Document: 0001654954-26-006756.txt0001654954-26-006756

Track record

42 reports on SNN

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +8.02% at T+20 after the Jun 30, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 12, 20264d ago 6-K Neutral 1/10 Entry $31.00 Now $30.97 −0.10% settles Nov 19
  2. Nov 4, 202612d ago 6-K Bearish 6/10 No price data
  3. Nov 4, 202612d ago 6-K Bearish 6/10 Entry $32.46 to $31.04 Now $30.97 +4.59% ▲ +4.37% +3.46% vs SPY
  4. Nov 2, 202614d ago 6-K Neutral 4/10 Entry $30.24 to $31.05 Now $30.97 +2.41% ▲ +2.68% +2.60% vs SPY
  5. Oct 22, 202625d ago 6-K Neutral 2/10 Entry $30.88 to $30.22 Now $30.97 +0.29% ▼ −2.14% −2.84% vs SPY
  6. Oct 8, 20265w ago 6-K Neutral 2/10 Entry $26.96 to $29.09 Now $30.97 +14.87% ▲ +7.90% +8.18% vs SPY
  7. Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
  8. Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
  9. Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
  10. Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
Showing 10 of 42

US Market Status

Market Closed · Opens Wed (10h 16m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 21, 2026